View this case discussion between Francis Mah, MD, and Kenneth A. Beckman, MD, to learn about the importance of treating the stages of neurotrophic keratitis and the available therapeutic agents.
Supported by an independent medical education grant from Dompé.
Upon completion of this activity, the participant should be able to:
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Francis S. Mah, MD
Director of Corneal and External Disease
Co-Director of Refractive Surgery
Scripps Clinic
La Jolla, CA
Kenneth A. Beckman, MD
Director of Corneal Services
Comprehensive Eye Care of Central Ohio
Westerville, Ohio
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Francis S. Mah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Eyenovia, Glaukos, iView, Johnson & Johnson Vision, Nevakar, Novartis, Ocular Science, and RxSight.
Kenneth A. Beckman, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Alcon Vision, Allergan, Avellino Labs, Bausch + Lomb, Biotissue, Bruder, Carl Zeiss Meditec, Dompe, Eyepoint, Eyevance, Glaukos, Glint, Johnson & Johnson, Kala, Leo Pharma, Novaliq, Novartis, Ocular Science, Ocular Therapeutix, Omeros, Sun Pharmaceuticals, Tearlab, Trefoil, and Visus.
The Evolve staff and planners have no financial relationships with commercial interests.
Mark Goerlitz-Jessen, MD, peer reviewer, has no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Dompé.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Eric D. Donnenfeld, MD
Marjan Farid, MD
Jason J. Jones, MD
Eva I. Liang, MD, FACS
Carlton Yuen, MD
Jennifer, I. Lim, MD, FASRS, FARVO
Jeremiah Brown Jr., MD, MS, FASRS
Rahul N. Khurana, MD, FASRS
